China Pharma Holdings, Inc. (CPHI) Balance Sheet
CPHI balance sheet, 2025
December 31, 2025 · U.S. dollars$31.0M assets = $8.3M liabilities + $22.7M equity
Both columns are drawn to the same scale: what CPHI owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CPHI financial health
Descriptive bands, not a rating. Fiscal 2025.
CPHI balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $78.5M2016 | $31.0M2025 | −9.8%/yr | |
| Total liabilities | $19.6M2016 | $8.3M2025 | −9.2%/yr | |
| Shareholders’ equity | $58.9M2016 | $22.7M2025 | −10.0%/yr | |
| Cash & short-term investments | $2.7M2016 | $345,1122025 | −20.3%/yr | |
| Total debt | $11.2M2016 | $3.9M2025 | −11.1%/yr | |
| Net cash (debt) | −$8.5M2016 | −$3.5M2025 | +$5.0M | |
| Working capital | $7.1M2016 | −$5.1M2025 | −$12.2M | |
| Book value per share | $0.702023 | $0.442024 | −36.9%/yr | |
| Current ratio | 1.682016 | 0.322025 | −1.37 | |
| Debt / equity | 0.192016 | 0.172025 | −0.02 | |
| Shares outstanding | 10.6M2023 | 17.5M2024 | +64.8%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CPHI assets
CPHI liabilities and equity
CPHI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CPHI balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $345,112 | $626,879 | $1.4M | $2.0M | $4.9M | $957,653 | $1.1M | $1.2M | $2.0M | $2.7M |
| Cash & equivalents | $345,112 | $626,879 | $1.4M | $2.0M | $4.9M | $957,653 | $1.1M | $1.2M | $2.0M | $2.7M |
| Short-term investments | — | $626.88B | $65,915 | $13,784 | $91,362 | $53,736 | $45,756 | $20,579 | $39,867 | $0 |
| Receivables | $290,673 | $281,068 | $728,307 | $464,454 | $835,401 | $529,544 | $682,014 | $1.1M | $2.5M | $4.2M |
| Inventory | $1.6M | $2.3M | $3.7M | $2.9M | $3.3M | $3.7M | $3.6M | $5.1M | $6.4M | $7.3M |
| Other current assets | $89,199 | $96,288 | $112,271 | $522,334 | $59,263 | $129,642 | $233,188 | $1.4M | $1.4M | $3.3M |
| Total current assets | $2.3M | $3.3M | $6.0M | $6.0M | $9.1M | $5.3M | $5.6M | $8.7M | $12.3M | $17.5M |
| Property, plant & equipment (net) | $4.6M | $4.5M | $6.8M | $9.6M | $13.0M | $15.2M | $16.0M | $18.9M | $23.1M | $24.6M |
| Goodwill & intangible assets | $24.08T | $6.7M | $4.1M | $2.2M | $589,624 | $613,827 | $609,366 | $676,055 | $831,766 | $940,327 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $391,836 | $0 | $0 | $0 | $0 | $0 | $17.1M | $23.7M | $35.5M |
| Total assets | $31.0M | $14.9M | $16.5M | $17.8M | $22.6M | $21.1M | $22.2M | $45.4M | $60.0M | $78.5M |
| Liabilities | ||||||||||
| Accounts payable | $891,083 | $225,106 | $966,420 | $667,082 | $926,749 | $1.2M | $1.4M | $1.1M | $1.1M | $3.1M |
| Short-term debt | $3.8M | $2.2M | $3.2M | $8.8M | $7.2M | $6.5M | $4.4M | $3.5M | $3.0M | $2.5M |
| Deferred revenue | $111,580 | $162,208 | $90,507 | $520,295 | $210,028 | $719,786 | $505,398 | $525,647 | $581,132 | $811,232 |
| Total current liabilities | $7.4M | $5.0M | $6.8M | $12.7M | $10.5M | $11.4M | $10.0M | $10.1M | $9.2M | $10.4M |
| Long-term debt | $0 | $1.4M | $1.4M | $0 | $5.2M | $904,228 | $2.2M | $4.4M | $6.9M | $1.4M |
| Lease obligations | $183,176 | $39,323 | $117,637 | $40,445 | $129,463 | $52,070 | $140,007 | $0 | $0 | $0 |
| Other long-term liabilities | $859,353 | $731,202 | $782,024 | $754,698 | $868,588 | $805,556 | $802,145 | $764,374 | $738,175 | $7.8M |
| Total liabilities | $8.3M | $7.1M | $9.0M | $13.5M | $16.6M | $13.1M | $13.0M | $15.2M | $16.9M | $19.6M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $15,522 | $32,618 | $10,625 | $74,909 | $47,340 | $45,580 | $43,580 | $43,580 | $43,580 | $43,580 |
| Retained earnings (deficit) | −$47.2M | −$44.0M | −$39.3M | −$36.2M | −$32.2M | −$28.8M | −$26.0M | −$5.3M | $5.5M | $24.8M |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | $11.6M | $11.3M | $11.5M | $11.6M | $12.6M | $12.3M | $11.6M | $11.8M | $14.0M | $10.5M |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $22.7M | $7.7M | $7.5M | $4.3M | $6.0M | $8.0M | $9.2M | $30.2M | $43.1M | $58.9M |
| Key figures | ||||||||||
| Total debt | $3.9M | $3.6M | $4.6M | $8.8M | $12.5M | $7.4M | $6.6M | $7.8M | $9.9M | $11.2M |
| Net cash (debt) | −$3.5M | −$3.0M | −$3.2M | −$6.7M | −$7.6M | −$6.5M | −$5.5M | −$6.6M | −$7.9M | −$8.5M |
| Working capital | −$5.1M | −$1.7M | −$823,731 | −$6.8M | −$1.4M | −$6.1M | −$4.5M | −$1.3M | $3.1M | $7.1M |
| Tangible book value | −$24.08T | $1.1M | $3.4M | $2.1M | $5.4M | $7.4M | $8.6M | $29.5M | $42.2M | $58.0M |
| Book value per share | — | $0.44 | $0.70 | — | — | — | — | — | — | — |
| Shares outstanding | — | 17.5M | 10.6M | — | — | — | — | — | — | — |
| Current ratio | 0.32 | 0.65 | 0.88 | 0.47 | 0.86 | 0.47 | 0.56 | 0.87 | 1.33 | 1.68 |
| Quick ratio | 0.09 | 0.18 | 0.32 | 0.20 | 0.54 | 0.13 | 0.17 | 0.23 | 0.49 | 0.66 |
| Debt / equity | 0.17 | 0.46 | 0.62 | 2.04 | 2.08 | 0.93 | 0.72 | 0.26 | 0.23 | 0.19 |
| Equity / assets | 73.4% | 52.0% | 45.3% | 24.1% | 26.6% | 37.9% | 41.5% | 66.6% | 71.8% | 75.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $304,874 | $168,474 | $345,112 | $267,625 | $625,032 | $412,688 | $626,879 | $718,691 | $739,337 | $838,881 | $1.4M | $1.4M |
| Cash & equivalents | $304,874 | $168,474 | $345,112 | $267,625 | $625,032 | $412,688 | $626,879 | $718,691 | $739,337 | $838,881 | $1.4M | $1.4M |
| Short-term investments | — | — | — | $26,697 | — | — | — | $26,943 | $15,435 | $65,915 | — | — |
| Receivables | $248,248 | $257,919 | $241,412 | $312,610 | $317,154 | $367,947 | $281,068 | $406,867 | $298,945 | $390,985 | $504,448 | $397,156 |
| Inventory | $1.4M | $1.5M | $1.6M | $1.6M | $1.7M | $2.0M | $2.3M | $2.5M | $2.8M | $3.7M | $3.7M | $3.8M |
| Other current assets | $91,073 | $74,279 | $138,460 | $99,510 | $79,836 | $91,323 | $96,288 | $114,568 | $115,771 | $215,338 | $336,130 | $273,257 |
| Total current assets | $2.0M | $2.0M | $2.3M | $2.3M | $2.7M | $2.9M | $3.3M | $3.7M | $4.0M | $5.1M | $6.0M | $5.8M |
| Property, plant & equipment (net) | $4.4M | $4.5M | $4.2M | $4.3M | $4.2M | $4.4M | $4.5M | $5.0M | $5.5M | $6.2M | $6.8M | $7.5M |
| Goodwill & intangible assets | $38.3M | $38.7M | $24.5M | $9.2M | $6.8M | $7.0M | $7.1M | $5.2M | $4.8M | $4.9M | $3.7M | $2.0M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $180,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $44.7M | $45.3M | $31.0M | $15.8M | $13.8M | $14.2M | $14.9M | $13.5M | $14.3M | $16.2M | $16.5M | $15.4M |
| Liabilities | ||||||||||||
| Accounts payable | $734,042 | $837,108 | $891,083 | $588,739 | $530,729 | $548,257 | $225,106 | $390,239 | $141,036 | $647,828 | $966,420 | $831,298 |
| Short-term debt | $3.7M | $3.8M | — | $3.4M | $2.1M | $2.1M | $2.2M | $2.6M | $2.7M | $2.7M | — | $3.9M |
| Deferred revenue | $153,642 | $61,746 | — | $120,912 | $77,683 | $114,435 | $162,208 | $24,920 | $101,056 | $112,357 | — | $172,110 |
| Total current liabilities | $7.7M | $7.3M | $7.4M | $6.6M | $5.3M | $5.1M | $5.0M | $4.8M | $4.7M | $5.7M | $6.8M | $7.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $1.3M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M | $1.4M |
| Lease obligations | $148,360 | $163,680 | $183,176 | $198,583 | $0 | $19,776 | $39,323 | $60,241 | $78,628 | $98,292 | $117,637 | $134,794 |
| Other long-term liabilities | $847,021 | $851,922 | $859,353 | $867,990 | $734,246 | $732,241 | $731,202 | $750,089 | $737,522 | $760,836 | $782,024 | $790,872 |
| Total liabilities | $8.5M | $8.1M | $8.3M | $7.5M | $7.3M | $7.2M | $7.1M | $6.9M | $6.9M | $7.9M | $9.0M | $9.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $40,522 | $40,522 | — | $5,022 | $3,262 | $3,262 | $32,618 | $17,859 | $17,162 | $14,816 | — | $104,773 |
| Retained earnings (deficit) | −$49.8M | −$48.4M | −$47.2M | −$46.0M | −$45.3M | −$44.8M | −$44.0M | −$42.8M | −$41.7M | −$40.2M | −$39.3M | −$38.1M |
| Accumulated other comprehensive income | $12.6M | $12.0M | — | $11.4M | $11.3M | $11.3M | $11.3M | $11.5M | $11.4M | $11.4M | — | $11.3M |
| Total shareholders' equity | $36.2M | $37.2M | $22.7M | $8.3M | $6.5M | $7.0M | $7.7M | $6.5M | $7.4M | $8.3M | $7.5M | $6.1M |
| Key figures | ||||||||||||
| Total debt | $3.8M | $3.9M | — | $3.6M | $3.4M | $3.5M | $3.6M | $4.0M | $4.1M | $4.2M | $1.4M | $5.4M |
| Net cash (debt) | −$3.4M | −$3.7M | — | −$3.3M | −$2.8M | −$3.1M | −$3.0M | −$3.3M | −$3.3M | −$3.3M | $11,947 | −$4.0M |
| Working capital | −$5.7M | −$5.3M | −$5.1M | −$4.3M | −$2.5M | −$2.3M | −$1.7M | −$1.0M | −$739,057 | −$603,747 | −$823,731 | −$1.3M |
| Tangible book value | −$2.2M | −$1.5M | −$1.7M | −$857,446 | −$371,585 | $7,534 | $660,632 | $1.4M | $2.6M | $3.4M | $3.8M | $4.1M |
| Book value per share | — | — | $1.47 | — | — | — | — | — | — | — | $0.70 | — |
| Shares outstanding | — | — | 15.5M | — | — | — | — | — | — | — | 10.6M | — |
| Current ratio | 0.26 | 0.28 | 0.32 | 0.35 | 0.51 | 0.56 | 0.65 | 0.79 | 0.84 | 0.89 | 0.88 | 0.82 |
| Quick ratio | 0.07 | 0.06 | 0.08 | 0.09 | 0.18 | 0.15 | 0.18 | 0.24 | 0.22 | 0.21 | 0.28 | 0.25 |
| Debt / equity | 0.10 | 0.10 | — | 0.43 | 0.53 | 0.50 | 0.46 | 0.61 | 0.55 | 0.50 | 0.19 | 0.88 |
| Equity / assets | 80.9% | 82.1% | 73.4% | 52.6% | 46.9% | 49.0% | 52.0% | 48.5% | 51.9% | 51.2% | 45.3% | 39.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed April 1, 2026); data from EODHD.
CPHI financial position
At the end of fiscal 2025 (December 31, 2025), China Pharma had total assets of $31.0 million (up 108.2% from a year earlier), total liabilities of $8.3 million and shareholders' equity of $22.7 million. It held $0.3 million in cash and short-term investments against $3.9 million of debt, net debt of $3.5 million. Its current ratio was 0.32. In the latest quarter (ended June 30, 2026) total assets were $44.7 million and equity $36.2 million.
Related: CPHI income statement, CPHI cash flow statement, CPHI key metrics. See the CPHI stock overview for the latest quote and news.
CPHI balance sheet FAQ
What are China Pharma's total assets?
China Pharma reported total assets of $31.0 million at the end of fiscal 2025 (December 31, 2025), compared with $14.9 million a year earlier.
How much debt does China Pharma have?
China Pharma had $3.9 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.17.
How much cash does China Pharma have?
China Pharma held $0.3 million in cash and short-term investments at the end of fiscal 2025; with $3.9 million of debt that is net debt of $3.5 million.
What is China Pharma's book value?
China Pharma's shareholders' equity (book value) was $22.7 million at the end of fiscal 2025.
What is China Pharma's current ratio?
China Pharma had current assets of $2.3 million and current liabilities of $7.4 million, a current ratio of 0.32 (current liabilities exceed current assets).
How much goodwill does China Pharma have?
China Pharma carried $24.08 trillion of goodwill and intangible assets, 77,676,391.4% of total assets, at the end of fiscal 2025.